A multicenter, retrospective study evaluating the efficacy of alectinib or crizotinib ALK-rearranged non-small cell lung cancer patients
Latest Information Update: 08 Oct 2016
At a glance
- Drugs Alectinib (Primary) ; Crizotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 08 Oct 2016 New trial record